AI in Drug Development helps Pharma Cut Trial Admin Time

AI in Drug Development is cutting trial setup and regulatory paperwork, with Novartis and GSK citing major time and cost savings.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Tagged Agentic AI, AI In Drug Development, Anthropic, Artificial Intelligence, AstraZeneca, clinical trials, Genmab, GSK, JP Morgan Healthcare Conference, Microsoft Copilot, Novartis, Nvidia, Pharma Operations, Regulatory Submissions, Teva